You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 25, 2025

Drug Price Trends for PEG


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for PEG

Average Pharmacy Cost for PEG

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
PEG-3350 AND ELECTROLYTES SOLN 64380-0766-21 0.00460 ML 2025-04-23
PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G 00093-3560-26 71.07539 EACH 2025-04-23
PEG-3350 AND ELECTROLYTES SOLN 10572-0100-01 0.00460 ML 2025-04-23
PEG3350-SOD SUL-NACL-KCL-ASCB-C 100-7.5-2.691-1.015-5.9-4.7G 68682-0201-75 71.07539 EACH 2025-04-23
PEG 3350-ELECTROLYTE SOLUTION 10572-0302-01 0.00613 ML 2025-04-23
PEGASYS 180 MCG/ML VIAL 82154-0449-01 1070.90400 ML 2025-04-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for PEG

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
PEG-3350/ELECTROLYTES PWDR Sebela Pharmaceuticals, Inc. DBA Sebela Pharmaceuticals, Inc. 10572-0100-01 4000ML 0.01 ML 2024-04-01 - 2029-03-31 Big4
GOLYTELY Sebela Pharmaceuticals, Inc. DBA Sebela Pharmaceuticals, Inc. 52268-0100-01 4000ML 14.19 0.00355 ML 2024-04-01 - 2029-03-31 Big4
PEG-3350/ELECTROLYTES PWDR Sebela Pharmaceuticals, Inc. DBA Sebela Pharmaceuticals, Inc. 10572-0100-01 4000ML 19.65 0.00491 ML 2024-04-01 - 2029-03-31 FSS
GOLYTELY Sebela Pharmaceuticals, Inc. DBA Sebela Pharmaceuticals, Inc. 52268-0100-01 4000ML 19.66 0.00492 ML 2024-04-01 - 2029-03-31 FSS
PEG-3350/ELECTROLYTES PWDR Sebela Pharmaceuticals, Inc. DBA Sebela Pharmaceuticals, Inc. 10572-0100-01 4000ML 6.95 0.00174 ML 2024-05-15 - 2029-03-31 Big4
SUFLAVE Sebela Pharmaceuticals, Inc. DBA Sebela Pharmaceuticals, Inc. 52268-0550-01 1 88.89 88.89000 EACH 2024-04-01 - 2029-03-31 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Polyethylene Glycol (PEG) Market Analysis and Price Projections

Market Overview

The global polyethylene glycol (PEG) market is poised for significant growth, driven by increasing demand from various end-use industries, particularly pharmaceuticals and cosmetics & personal care.

  • Current Market Value: The global PEG market was valued at USD 3.94 billion in 2024 and is expected to reach USD 5.31 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 6.2% from 2024 to 2029[1].
  • Future Projections: By 2034, the market is anticipated to achieve a valuation of USD 7,999.4 million, growing at a CAGR of 6.4% from 2024 to 2034[2].

Key Drivers of Market Growth

Pharmaceutical Industry

The pharmaceutical sector is a major driver of the PEG market. PEG is essential in enhancing drug formulations and delivery systems due to its properties such as solubility, non-toxicity, and the ability to improve drug absorption rates. With the aging global population and the increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular diseases, the demand for efficient and advanced treatments is rising. PEG's ability to increase the solubility, bioavailability, and stability of formulations makes it vital for the manufacturing of oral, topical, and injectable medicines[1][4].

Cosmetics and Personal Care

PEG is widely used in the cosmetics and personal care industry as a humectant and emulsifier. Its emollient properties make it a preferred ingredient in skin care products, contributing to the market's growth[1][2].

Industrial Applications

The demand for water-soluble polymers in industrial applications, such as in the construction and automotive industries, is also driving the PEG market. The use of PEG in water-based coatings, paints, and inks is becoming more prevalent due to its material properties like non-toxicity and wear resistance[3].

Regional Analysis

Asia Pacific

The Asia Pacific region is expected to witness high growth during the forecast period. Rapid industrial growth, increasing investments in healthcare, and the rise in demand across various end-use industries in countries like India and China are driving the market. Government policies supporting industrial growth and significant investments in healthcare infrastructure further enhance PEG applications in this region[1][4].

Europe

Europe is another lucrative region, anchored by its well-established pharmaceutical industry, stringent regulatory compliance, and robust healthcare infrastructure. The region's emphasis on research and development also contributes to its attractiveness[4].

Challenges and Restraints

Raw Material Costs

Fluctuations in crude oil prices, which influence the cost of ethylene oxide (the primary raw material for PEG), can impact the profit margins of PEG manufacturers. When crude oil prices rise, it can lead to reduced demand from price-sensitive industries such as pharmaceuticals and personal care, as customers may seek alternative options[1].

Price Sensitivity

Small and medium enterprises in the PEG market may face difficulties in absorbing sudden price hikes, leading to reduced profit margins and potential declines in demand from price-sensitive customers[1].

Technological Advancements and Innovations

PEGylation Technology

Developments in PEGylation technology, which modifies drugs to enhance their pharmacokinetic properties, are fueling the market. PEGylation helps increase the life of therapeutic proteins, making them more effective over an extended period[1].

Biodegradable PEG

Research and development in manufacturing technologies, including the development of biodegradable PEG, are expanding the application and efficiency of PEG products across various industries[1].

Market Opportunities

Long-Acting Medications

The increasing demand for long-acting medications provides a significant growth opportunity for the PEG market. PEG plays a critical role in drug formulations and delivery systems, especially for medications that require slow release of active ingredients over a period of time[1].

Personalized Medicines and Biologics

The rise in personalized medicines and biologics has resulted in increased focus on drug delivery systems, further fueling the demand for PEG[1].

Price Projections

  • Short-Term: The market is expected to grow at a CAGR of 6.2% from 2024 to 2029, reaching a valuation of USD 5.31 billion by 2029[1].
  • Long-Term: By 2034, the market is projected to reach a valuation of USD 7,999.4 million, growing at a CAGR of 6.4% from 2024 to 2034[2].

Key Takeaways

  • The global PEG market is driven by increasing demand from pharmaceuticals, cosmetics & personal care, and industrial applications.
  • The Asia Pacific region is expected to be the fastest-growing market due to rapid industrial growth and increasing healthcare investments.
  • Technological advancements in PEGylation and the development of biodegradable PEG are expanding market opportunities.
  • Fluctuations in crude oil prices can impact the cost and demand for PEG products.
  • The market is projected to reach USD 5.31 billion by 2029 and USD 7,999.4 million by 2034.

Frequently Asked Questions (FAQs)

Q: What are the primary applications of Polyethylene Glycol (PEG)? A: PEG is primarily used in the pharmaceutical industry to enhance drug formulations and delivery systems, and in the cosmetics and personal care industry as a humectant and emulsifier[1][2].

Q: Which region is expected to witness the highest growth in the PEG market? A: The Asia Pacific region is expected to witness the highest growth due to rapid industrial growth, increasing healthcare investments, and rising demand across various end-use industries[1][4].

Q: How do fluctuations in crude oil prices affect the PEG market? A: Fluctuations in crude oil prices can impact the cost of raw materials used in PEG manufacturing, reducing profit margins and potentially leading to reduced demand from price-sensitive industries[1].

Q: What role does PEGylation technology play in the PEG market? A: PEGylation technology modifies drugs to enhance their pharmacokinetic properties, increasing the life of therapeutic proteins and making them more effective over an extended period[1].

Q: What are the long-term growth projections for the PEG market? A: The PEG market is projected to reach a valuation of USD 7,999.4 million by 2034, growing at a CAGR of 6.4% from 2024 to 2034[2].

Cited Sources

  1. MarketsandMarkets: Polyethylene Glycol Market, Industry Size Forecast Report [Latest][1].
  2. GlobeNewswire: Polyethylene Glycol Market Trends Highlight Robust Demand and USD 7,999.4 million Valuation by 2034[2].
  3. Grand View Research: Polyethylene Glycol Market Size And Share Report, 2030[3].
  4. Verified Market Research: Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size And Forecast[4].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.